Keros Therapeutics Inc (KROS)

16.77 +0.06 (+0.36%) USD  |  NASDAQ  |  Dec 26, 15:30
More

Keros Therapeutics Cash and Short Term Investments (Quarterly): 530.68M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Aptevo Therapeutics Inc 7.753M
Corcept Therapeutics Inc 380.34M
Regeneron Pharmaceuticals Inc 9.796B
Scholar Rock Holding Corp 139.06M
Trevi Therapeutics Inc 65.49M